Flanagan Joseph Gerard
- SEC CIK
- 0001413644
No open-market purchases or sales filed in the past year.
Current role at each company
- RCM R1 RCM Inc.Directoras of Nov 19, 2024
- GOCO GoHealth, Inc.Directoras of May 24, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Flanagan Joseph Gerard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RCM R1 RCM Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 (view filing) | Aug 16-18 | 2 days | Flanagan Joseph GerardChief Executive Officer | SSale | −600.0K | $25.06 | −$15.0M | −17.7%2.79M after | 4 lots |
| Nov 12, 2021 (view filing) | Nov 9-11 | 3 days | Flanagan Joseph GerardPresident and CEO | SSale | −239.4K | $25.48 | −$6.10M | −8.7%2.51M after | 3 lots |
| Oct 14, 2021 (view filing) | Oct 12-14 | 2 days | Flanagan Joseph GerardPresident and CEO | SSale | −130.5K | $23.11 | −$3.02M | −4.9%2.51M after | 3 lots |